As of 2026-03-20, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is -18.24 USD. This RAPT valuation is based on the model Peter Lynch Fair Value. With the current market price of 58.02 USD, the upside of Rapt Therapeutics Inc is -131.43%.
Based on its market price of 58.02 USD and our intrinsic valuation, Rapt Therapeutics Inc (RAPT) is overvalued by 131.43%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -18.24 - -18.24 | -18.24 | -131.43% |
| P/E | (67.92) - (78.79) | (75.87) | -230.8% |
| DDM - Stable | (18.07) - (54.69) | (36.38) | -162.7% |
| DDM - Multi | (19.12) - (47.35) | (27.50) | -147.4% |
| Market Cap (mil) | 1,680.26 |
| Beta | 1.34 |
| Outstanding shares (mil) | 28.96 |
| Enterprise Value (mil) | 1,642.33 |
| Market risk premium | 4.60% |
| Cost of Equity | 14.07% |
| Cost of Debt | 5.00% |
| WACC | 8.87% |